litlas
ログインアカウント作成

Thomas F. Pajak

1980–2012 年に発表

別表記
THOMAS F. PAJAK
54
論文数
29,320
被引用数
54
h 指数
54
i10 指数

被引用数

Thomas F. Pajak の年別被引用数1979 年: 被引用 1 件1981 年: 被引用 1 件1982 年: 被引用 1 件1983 年: 被引用 3 件1984 年: 被引用 9 件1985 年: 被引用 4 件1986 年: 被引用 8 件1987 年: 被引用 8 件1988 年: 被引用 17 件1989 年: 被引用 13 件1990 年: 被引用 15 件1991 年: 被引用 26 件1992 年: 被引用 32 件1993 年: 被引用 45 件1994 年: 被引用 24 件1995 年: 被引用 46 件1996 年: 被引用 38 件1997 年: 被引用 52 件1998 年: 被引用 53 件1999 年: 被引用 52 件2000 年: 被引用 81 件2001 年: 被引用 116 件2002 年: 被引用 128 件2003 年: 被引用 123 件2004 年: 被引用 164 件2005 年: 被引用 185 件2006 年: 被引用 184 件2007 年: 被引用 214 件2008 年: 被引用 225 件2009 年: 被引用 182 件2010 年: 被引用 199 件2011 年: 被引用 190 件2012 年: 被引用 166 件2013 年: 被引用 153 件2014 年: 被引用 171 件2015 年: 被引用 153 件2016 年: 被引用 120 件2017 年: 被引用 145 件2018 年: 被引用 86 件2019 年: 被引用 512 件2020 年: 被引用 504 件2021 年: 被引用 350 件2022 年: 被引用 257 件2023 年: 被引用 168 件2024 年: 被引用 317 件2025 年: 被引用 129 件2026 年: 被引用 1 件1980 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,101 件、この内訳の 31.8%中国: 引用元論文 440 件、この内訳の 6.7%イギリス: 引用元論文 387 件、この内訳の 5.9%カナダ: 引用元論文 351 件、この内訳の 5.3%ドイツ: 引用元論文 310 件、この内訳の 4.7%フランス: 引用元論文 297 件、この内訳の 4.5%オランダ: 引用元論文 287 件、この内訳の 4.3%イタリア: 引用元論文 276 件、この内訳の 4.2%日本: 引用元論文 261 件、この内訳の 3.9%オーストラリア: 引用元論文 168 件、この内訳の 2.5%ベルギー: 引用元論文 165 件、この内訳の 2.5%インド: 引用元論文 148 件、この内訳の 2.2%
0%31.8%その他 21.5%

機関

分野

  • Medicine83.4%
  • Biochemistry, Genetics and Molecular Biology7.7%
  • Health Professions2.4%
  • Physics and Astronomy2%
  • Engineering1.5%
  • Immunology and Microbiology1.1%
  • その他1.9%

トピック

  • Head and Neck Cancer Studies14%
  • Esophageal Cancer Research and Treatment6.5%
  • Advanced Radiotherapy Techniques3.9%
  • Head and Neck Surgical Oncology3.5%
  • Oral health in cancer treatment3.3%
  • Effects of Radiation Exposure3.1%
  • その他65.7%

共著者

全論文

検索で開く
  1. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC)

    著者: James D. Cox, JoAnn Stetz, Thomas F. Pajak - International Journal of Radiation Oncology*Biology*Physics 1995 被引用: 4,820

  2. Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck

    著者: Jay S. Cooper, Thomas F. Pajak, Arlene A. Forastiere, John Jacobs, Bruce H. Campbell, Scott Saxman, Julie A. Kish, Harold E. Kim, Anthony J. Cmelak, Marvin Rotman, Mitchell Machtay, John F. Ensley, K. S. Clifford Chao, Christopher J. Schultz, Nancy Y. Lee, Karen K. Fu - New England Journal of Medicine 2004 被引用: 3,256

  3. Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)

    著者: Jacques Bernier, Jay S. Cooper, Thomas F. Pajak, M. van Glabbeke, Jean Bourhis, Arlene A. Forastiere, Esat Mahmut Özşahin, John R. Jacobs, Jacek Jassem, Kie-Kian Ang, Jean Louis Lefèbvre - Head & Neck 2005 被引用: 1,770

  4. Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal Cancer

    著者: Arlene A. Forastiere, Helmuth Goepfert, Moshe Maor, Thomas F. Pajak, Randal S. Weber, William H. Morrison, Bonnie S. Glisson, Andy Trotti, John A. Ridge, C. Chao, Glen Peters, Ding-Jen Lee, Andrea Leaf, John F. Ensley, Jay S. Cooper - New England Journal of Medicine 2003 被引用: 3,171

  5. Long-Term Results of RTOG 91-11: A Comparison of Three Nonsurgical Treatment Strategies to Preserve the Larynx in Patients With Locally Advanced Larynx Cancer

    著者: Arlene A. Forastiere, Qiang Zhang, Randal S. Weber, Moshe Maor, Helmuth Goepfert, Thomas F. Pajak, William H. Morrison, Bonnie S. Glisson, Andy Trotti, John A. Ridge, Wade L. Thorstad, Henry Wagner, John F. Ensley, Jay S. Cooper - Journal of Clinical Oncology 2012 被引用: 1,278

  6. Long-term Follow-up of the RTOG 9501/Intergroup Phase III Trial: Postoperative Concurrent Radiation Therapy and Chemotherapy in High-Risk Squamous Cell Carcinoma of the Head and Neck

    著者: Jay S. Cooper, Qiang Zhang, Thomas F. Pajak, Arlene A. Forastiere, John R. Jacobs, Scott Saxman, Julie A. Kish, Harold E. Kim, Anthony J. Cmelak, Marvin Rotman, Robert A. Lustig, John F. Ensley, Wade L. Thorstad, Christopher J. Schultz, Sue S. Yom, K. Kian Ang - International Journal of Radiation Oncology*Biology*Physics 2012 被引用: 605

  7. INT 0123 (Radiation Therapy Oncology Group 94-05) Phase III Trial of Combined-Modality Therapy for Esophageal Cancer: High-Dose Versus Standard-Dose Radiation Therapy

    著者: Bruce D. Minsky, Thomas F. Pajak, Robert J. Ginsberg, Thomas M. Pisansky, James A. Martenson, Ritsuko Komaki, Gordon Okawara, Seth A. Rosenthal, David P. Kelsen - Journal of Clinical Oncology 2002 被引用: 1,130

  8. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis

    著者: Jean Bourhis, Jens Overgaard, Hélène Audry, Kian Ang, Michele I. Saunders, Jacques Bernier, Jean-Claude Horiot, Aurélie Le Maître, Thomas F. Pajak, Michael Poulsen, Brian O’Sullivan, W. Dobrowsky, A Hliniak, Krzysztof Składowski, John Hay, Luiz HJ Pinto, C. Fallai, Karen K. Fu, Richard Sylvester, Jean‐Pierre Pignon - The Lancet 2006 被引用: 1,075

  9. A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003

    著者: Karen K. Fu, Thomas F. Pajak, Andy Trotti, Christopher U. Jones, Sharon A. Spencer, Theodore L. Phillips, Adam S. Garden, John A. Ridge, Jay S. Cooper, K. Kian Ang - International Journal of Radiation Oncology*Biology*Physics 2000 被引用: 1,362

  10. Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data

    著者: Stefan Michiels, Aurélie Le Maître, Marc Buyse, Tomasz Burzykowski, E. Maillard, Jan Bogaerts, Jan B. Vermorken, Wilfried Budach, Thomas F. Pajak, Kian Ang, Jean Bourhis, Jean‐Pierre Pignon - The Lancet Oncology 2009 被引用: 166

  11. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study.

    著者: Marshall S. Flam, Michelle E. St. John, Thomas F. Pajak, Nicholas J. Petrelli, Robert J. Myerson, Stephen Doggett, J.M. Quivey, Marvin Rotman, Herbert D. Kerman, L. Coia, K Murray - Journal of Clinical Oncology 1996 被引用: 1,089

  12. Chemotherapy Followed by Surgery Compared with Surgery Alone for Localized Esophageal Cancer

    著者: David P. Kelsen, Robert J. Ginsberg, Thomas F. Pajak, Daniel G. Sheahan, Leonard L. Gunderson, Joanne Mortimer, Norman Estes, Daniel G. Haller, Jaffer A. Ajani, Walter Kocha, Bruce D. Minsky, Jack A. Roth - New England Journal of Medicine 1998 被引用: 1,361

  13. A multinational, randomized phase iii trial of iseganan hcl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy

    著者: Andy Trotti, Adam S. Garden, Padraig Warde, Paul Symonds, Corey J. Langer, Rebecca Redman, Thomas F. Pajak, T. R. Fleming, Michael Henke, Jean Bourhis, David I. Rosenthal, Elizabeth Junor, Anthony J. Cmelak, Finbarr Sheehan, Janis Pulliam, Patricia Devitt-Risse, Henry J. Fuchs, Mark S. Chambers, Brian O’Sullivan, K. Kian Ang - International Journal of Radiation Oncology*Biology*Physics 2004 被引用: 139

  14. Phase III Trial of Long-Term Adjuvant Androgen Deprivation After Neoadjuvant Hormonal Cytoreduction and Radiotherapy in Locally Advanced Carcinoma of the Prostate: The Radiation Therapy Oncology Group Protocol 92–02

    著者: Gerald E. Hanks, Thomas F. Pajak, Arthur T. Porter, David J. Grignon, Harmart Brereton, Varagur Venkatesan, Eric M. Horwitz, C.A. Lawton, Seth A. Rosenthal, Howard M. Sandler, William U. Shipley - Journal of Clinical Oncology 2003 被引用: 694

  15. The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: A patterns-of-care study

    著者: Rachelle Lanciano, Thomas F. Pajak, Karen Martz, Gerald E. Hanks - International Journal of Radiation Oncology*Biology*Physics 1993 被引用: 338

  16. TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group

    著者: Andy Trotti, Thomas F. Pajak, Clement K. Gwede, Rebecca Paulus, Jay S. Cooper, Arlene A. Forastiere, John A. Ridge, Deborah Watkins Bruner, Adam S. Garden, K. Kian Ang, W.J. Curran - The Lancet Oncology 2007 被引用: 215

  17. Randomized study of preoperative versus postoperative radiation therapy in advanced head and neck carcinoma: Long-term follow-up of RTOG study 73-03

    著者: Leslie Tupchong, D Phil, Charles Scott, Peter H. Blitzer, Víctor A. Marcial, Louis D. Lowry, John R. Jacobs, Joann Stetz, Lawrence W. Davis, James B. Snow, Richard B. Chandler, Simon Krämer, Thomas F. Pajak - International Journal of Radiation Oncology*Biology*Physics 1991 被引用: 247

  18. Randomized Phase III Trial of Low-dose Isotretinoin for Prevention of Second Primary Tumors in Stage I and II Head and Neck Cancer Patients

    著者: Fadlo R. Khuri, J. Jack Lee, Scott M. Lippman, Edward S. Kim, Jay S. Cooper, Steven E. Benner, Rodger J. Winn, Thomas F. Pajak, Brendell Williams, George Shenouda, I. Hodson, Karen K. Fu, Dong M. Shin, Everett E. Vokes, Lei Feng, Helmuth Goepfert, Waun Ki Hong - JNCI Journal of the National Cancer Institute 2006 被引用: 238

  19. Second malignancies in patients who have head and neck cancer: Incidence, effect on survival and implications based on the RTOG experience

    著者: Jay S. Cooper, Thomas F. Pajak, Philip Rubin, Leslie Tupchong, Luther W. Brady, Steven A. Leibel, George E. Laramore, Víctor A. Marcial, Lawrence W. Davis, James D. Cox - International Journal of Radiation Oncology*Biology*Physics 1989 被引用: 385

  20. Effects of bolus volume, viscosity, and repeated swallows in nonstroke subjects and stroke patients

    著者: Cathy L. Lazarus, Jeri A. Logemann, Alfred Rademaker, Peter J. Kahrilas, Thomas F. Pajak, Richard Lazar, Anita S. Halper - Archives of Physical Medicine and Rehabilitation 1993 被引用: 243

  21. Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck. An RTOG study

    著者: Muhyi Al‐Sarraf, Thomas F. Pajak, Víctor A. Marcial, Phyllis Ager Mowry, Jay S. Cooper, Joann Stetz, John F. Ensley, E Vélez-García - Cancer 1987 被引用: 209

  22. Precisely defining high-risk operable head and neck tumors based on rtog #85-03 and #88-24: Targets for postoperative radiochemotherapy?

    著者: Jay S. Cooper, Thomas F. Pajak, Arlene A. Forastiere, John Jacobs, Karen K. Fu, Kian Ang, George E. Laramore, Muhyi Al‐Sarraf - Head & Neck 1998 被引用: 172

  23. Hyperfractionated or accelerated radiotherapy for head and neck cancer

    著者: B. Baujat, Jean Bourhis, Pierre Blanchard, Jens Overgaard, Kian Ang, M.I. Saunders, Aurélie Le Maître, Jacques Bernier, Jean Claude Horiot, E. Maillard, Thomas F. Pajak, Michael Poulsen, Abderrahmane Bourredjem, Brian O’Sullivan, W. Dobrowsky, A Hliniak, Krzysztof Składowski, John Hay, Luiz HJ Pinto, Karen K. Fu, C. Fallai, Richard Sylvester, Jean‐Pierre Pignon, MARCH Collaborative Group - Cochrane Database of Systematic Reviews 2010 被引用: 108

  24. Diffuse Malignant Mesothelioma

    著者: A. Philippe Chahinian, THOMAS F. PAJAK, JAMES F. HOLLAND, LARRY NORTON, ROY M. AMBINDER, EUGEN M. MANDEL - Annals of Internal Medicine 1982 被引用: 358